|
End-of-day quote
Nasdaq Riga
|
||
| - LVL | - |
|
| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2021-06-18 | |
Janis Buks
CHM | Chairman | - | 2022-08-31 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -3.11% | +13.82% | +60.66% | 46.21B | |
| -1.13% | -5.78% | +33.26% | +108.13% | 38.78B | |
| +0.12% | -0.08% | +7.12% | +78.27% | 11.68B | |
| -0.53% | -1.37% | -13.25% | +10.18% | 11.55B | |
| -0.38% | -2.26% | +18.18% | +139.63% | 9.14B | |
| +0.32% | -2.26% | +23.08% | +34.73% | 7.3B | |
| +0.17% | -0.74% | +13.44% | +197.13% | 7.15B | |
| -1.00% | -5.25% | +34.34% | -19.63% | 7.1B | |
| -3.13% | -4.30% | -44.88% | +11.66% | 4.97B | |
| Average | -0.74% | -2.59% | +9.46% | +68.97% | 15.99B | |
| Weighted average by Cap. | -0.86% | -3.27% | +16.06% | +75.66% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
